The following is the full transcript of the interview with International Atomic Energy Agency Director-General Rafael Grossi, ...

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2025 Earnings Call Transcript March 19, 2026 Taysha Gene Therapies, Inc. beats earnings expectations. Reported EPS is $-0.08711, expectations were ...

The Pentagon’s attack on Anthropic is a signal of government-sanctioned suppression, Trump’s former A.I. adviser Dean Ball ...

Alignment Healthcare Inc. (ALHC) reported better-than-expected financial results for the fourth quarter of 2025, with a narrower loss than anticipated and higher revenue. The company’s earnings per ...

Shenouda With me on today's call are Relmada Therapeutics, Inc.'s CEO, Dr. Sergio Traversa, who will briefly provide a summary of recent business highlights; Dr. Raj S. Pruthi, Relmada Therapeutics, ...

Joining me on today’s call are Sean Nolan, Taysha Gene Therapies, Inc.'s Chief Executive Officer; Sukumar Nagendran, ...

Christian Arnell Christensen & Associates. Today's presentation will be conducted in English and will consist of prepared remarks reviewing the group's financial and operational p ...

Earnings call ALHC posted 44% revenue growth in Q4 2025 and 46% for the full year, with adjusted EBITDA surging to $110M from breakeven last year. Membership grew 25% YoY, and margins improved across ...

Q3 2026 Earnings Call March 19, 2026 5:30 PM EDTCompany ParticipantsJenifer Hollander - Vice President of Investor ...

The FCC sent a draft notice of proposed rulemaking (NPRM) regarding Positioning, Navigation, and Timing (PNT) technology to ...